Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.
Published August 17, 2022 · Recall initiated: August 2, 2022
Summary
FDA records drug Class II recall D-1328-2022, published August 17, 2022 and initiated August 2, 2022. Recalling firm: CIPLA; Status: Terminated; Reported quantity: 7,992 bottles; Lot: Lot # DEG3LC2, Exp 05/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Complaints received of defective container closure.
What to do
Voluntary: Firm initiated · Letter
Get an email if DIFLUPREDNATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIFLUPREDNATE
- Manufacturer
- CIPLA
- Distributor
- Nationwide in the USA
- Lot
- Lot # DEG3LC2, Exp 05/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADifluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India,September 14, 2022
- FDAAlcohol Swabsticks, Antiseptic, 50 4" saturated individual packets per box, Manufactured for: DynarexAugust 17, 2022
- FDALamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TNAugust 17, 2022
- FDASterile Alcohol Prep Pads, Sterile, Latex Free, 100 large pads per box, manufactured for: Dynarex Corporation,August 17, 2022
- FDAPrednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd.,August 17, 2022
- FDADifluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S IndocoJuly 27, 2022
Questions about this recall
Was Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35. recalled?
Yes. FDA published recall D-1328-2022 on August 17, 2022. Reported hazard: Lack of Assurance of Sterility: Complaints received of defective container closure.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIFLUPREDNATE.